India, July 15 -- The Maharashtra Food and Drug Administration (FDA) has suspended the licence of the Metro Blood Bank at Aundh District Hospital (ADH) after inspections found serious violations in technical supervision, blood component processing, sterility testing and record maintenance, officials said.

The action is part of a wider crackdown in which 10 blood centres in Pune district had their licences suspended between April and June 2026, the highest in Maharashtra, according to the FDA.

The Metro Blood Bank, which received licences from the Central Drugs Standard Control Organisation (CDSCO) and the FDA in September 2023 after a decade-long wait, is a major blood component separation centre serving Pune district.

FDA officials sa...